Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2022	$ 3	$ 117,542	$ (95,795)	$ 21,750
Balance at beginning of period (shares) at Dec. 31, 2022	3,179
Increase (Decrease) in Stockholders' Equity
Issuance of stock from exercise of warrants	$ 2	7,181		7,183
Issuance of stock from exercise of warrants (in shares)	1,702
Stock-based compensation		222		222
Issuance of stock for vested restricted stock units (in shares)	25
Net loss			(12,470)	(12,470)
Balance at end of period at Dec. 31, 2023	$ 5	124,945	(108,265)	16,685
Balance at end of period (shares) at Dec. 31, 2023	4,906
Increase (Decrease) in Stockholders' Equity
Issuance of stock from exercise of warrants	$ 1			1
Issuance of stock from exercise of warrants (in shares)	351
Stock-based compensation		538		538
Issuance of common stock and warrants under the securities purchase agreements, net of issuance costs	$ 3	18,035		18,038
Issuance of common stock and warrants under the securities purchase agreements, net of issuance costs (in shares)	3,308
Issuance of placement agent warrants		309		309
Issuance of stock for vested restricted stock units, net of shares withheld for withholding taxes		(48)		(48)
Issuance of stock for vested restricted stock units, net of shares withheld for withholding taxes (in shares)	72
Net loss			(27,592)	(27,592)
Balance at end of period at Dec. 31, 2024	$ 9	$ 143,779	$ (135,857)	$ 7,931
Balance at end of period (shares) at Dec. 31, 2024	8,637